P2.14-02 TP53 Mutations Affect Sensitivity to Lorlatinib in ROS1 Positive NSCLC: Final Results of the PFROST Trial
| Autor: | Landi, L., Tiseo, M., Heukamp, L.C., Menon, R., de Marinis, F., Minuti, G., Cortinovis, D.L., Delmonte, A., Galetta, D., Bertrand, M., Zacher, A., Gridelli, C., Jacobs, F., Chiari, R., Verusio, C., Giannarelli, D., Crinò, L., Cappuzzo, F. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology September 2022 17(9) Supplement:S157-S157 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|